Lapaquistat acetate
Lapaquistat acetate (TAK-475) is a squalene synthase inhibitor, blocking the conversion of farnesyl diphosphate (FPP) to squalene in the cholesterol biosynthesis pathway[1]. Lapaquistat acetate is effective at lowering low-density lipoprotein cholesterol, but it might cause liver damage. Lapaquistat acetate is used for hypercholesterolemia and mevalonate kinase deficiency (MKD) research[2].
Product Specifications
CAS Number
189060-13-7
Product Name Alternative
TAK-475
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Farnesyl Transferase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/lapaquistat-acetate.html
Purity
99.10
Solubility
DMSO : 2 mg/mL (ultrasonic)
Smiles
O=C(O)CC1CCN(C(C[C@@H]2C(N(CC(C)(C)COC(C)=O)C3=CC=C(Cl)C=C3[C@@H](C4=CC=CC(OC)=C4OC)O2)=O)=O)CC1
Molecular Formula
C33H41ClN2O9
Molecular Weight
645.14
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Inhibin alpha (INHA) Mouse Monoclonal Antibody [Clone ID: 4E2]](https://cdn.genprice.uk/products/937/68dd189a061270361e8fc0a4/imageurl/am06527su-n.webp)
Inhibin alpha (INHA) Mouse Monoclonal Antibody [Clone ID: 4E2]
HCG-beta (HCGb/54+ HCGb/459), CF740 conjugate, 0.1mg/mL
